Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Gains from Investment Securities (2017 - 2025)

Dianthus Therapeutics has reported Gains from Investment Securities over the past 6 years, most recently at $2.4 million for Q3 2025.

  • Quarterly results put Gains from Investment Securities at $2.4 million for Q3 2025, up 2551.0% from a year ago — trailing twelve months through Sep 2025 was $2.4 million (up 2551.0% YoY), and the annual figure for FY2024 was $4.5 million, up 157.2%.
  • Gains from Investment Securities for Q3 2025 was $2.4 million at Dianthus Therapeutics, up from $1.6 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for DNTH hit a ceiling of $4.5 million in Q4 2024 and a floor of -$46000.0 in Q4 2023.
  • Median Gains from Investment Securities over the past 3 years was $1.6 million (2025), compared with a mean of $1.9 million.
  • Biggest five-year swings in Gains from Investment Securities: surged 9881.96% in 2024 and later surged 2551.0% in 2025.
  • Dianthus Therapeutics' Gains from Investment Securities stood at -$46000.0 in 2023, then surged by 9881.96% to $4.5 million in 2024, then tumbled by 47.36% to $2.4 million in 2025.
  • The last three reported values for Gains from Investment Securities were $2.4 million (Q3 2025), $1.6 million (Q1 2025), and $4.5 million (Q4 2024) per Business Quant data.